FDA Warns: Weck Hem-o-Lok Ligating Clip Not Safe for Renal Artery Ligation

The FDA has informed health care providers that the Weck Hem-o-Lok Ligating Clip could cause serious risk for the donor when used for renal artery ligation during a laparoscopic living-donor nephrectomy and should not be used.

The FDA states, “the Weck Hem-o-Lok Ligating Clip is a V-shaped clip made from a non-absorbable material that comes in various sizes. It is used to permanently close bleeding vessels or tissue structures.”

During surgery, the FDA has found that clips can become dislodged during surgery. This causes the following issues:

  • uncontrolled bleeding
  • additional surgery
  • death of the donor.

The manufacturer of these clips added this information to the Instructions for use in 2006. Between 2001 and 2005 15 reports of 12 injuries and three deaths were submitted necessitating this label change. Since this label change, there have been three more kidney donor deaths all of which were associated with the aforementioned issues.

Both the Organ Procurement and Transplantation Network (OPTN) and the American Society of Transplant Surgeons issued have sent separate notifications to their members and to all OPTN-sanctioned kidney transplant systems involving living donors.
The FDA States:
“To help us learn as much as possible about the adverse events associated with Hem-o-Lok Ligating Clips, please include the following information in your reports:
• Manufacturer’s Name
• Device Name (Brand Name)
• Date Device was Manufactured
• Distributor’s Name
• Details of Adverse Event and Medical and/or Surgical Interventions
• Complete and submit the report Online: www.fda.gov/MedWatch/report.htm

Latest News from Pharma-Watch

FDA convenes to determine Fosamax bone fracture dangers

The New York Times Reports: In light of evidence linking the long-term use of Fosamax and femur fractures, the FDA said it plans to convene Friday to determine whether it will recommend suspending the use of the osteoporosis drug.

Spine Specialists Discredit Medtronic Bone Growth Product

June 29th, 2011 “It harms patients to have biased and corrupted research published…It harms patients to have unaccountable special interests permeate medical research,” read an excerpt from an

CT Brain Perfusion Scan Risks

The FDA released an advisory to consumers in October regarding the CT Bran Profusion Scan manufactured by GE. The advisory states that the scans default radiation therapy is set to high for most patient

Risk of death found in sleeping pill use -- Scripps

Scripps Study: Sleeping pills believed a cause of 500,000 premature deaths annually (March 1, 2012) Pick 10 people at random and ask them if they take sleeping pills. Chances are at least one of them

FDA pulls approval of Avastin breast cancer drug

Avastin no longer allowed for breast cancer The U.S. Food & Drug Administration has revoked its approval of Avastin after concluding the metastatic breast cancer treatment did nothing to control tumor